Gendler SJ - Search Results

1

Epithelial mucin genes.

Gendler SJ, Spicer AP. Gendler SJ, et al. Annu Rev Physiol. 1995;57:607-34. doi: 10.1146/annurev.ph.57.030195.003135. Annu Rev Physiol. 1995. PMID: 7778880 Review.

2

Therapeutic efficacy of MUC1-specific cytotoxic T lymphocytes and CD137 co-stimulation in a spontaneous breast cancer model.

Mukherjee P, Tinder TL, Basu GD, Pathangey LB, Chen L, Gendler SJ. Mukherjee P, et al. Among authors: gendler sj. Breast Dis. 2004;20:53-63. doi: 10.3233/bd-2004-20107. Breast Dis. 2004. PMID: 15687707 Review.

3

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine.

Lakshminarayanan V, Thompson P, Wolfert MA, Buskas T, Bradley JM, Pathangey LB, Madsen CS, Cohen PA, Gendler SJ, Boons GJ. Lakshminarayanan V, et al. Among authors: gendler sj. Proc Natl Acad Sci U S A. 2012 Jan 3;109(1):261-6. doi: 10.1073/pnas.1115166109. Epub 2011 Dec 14. Proc Natl Acad Sci U S A. 2012. PMID: 22171012 Free PMC article.

4

Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB pathways.

Thompson EJ, Shanmugam K, Hattrup CL, Kotlarczyk KL, Gutierrez A, Bradley JM, Mukherjee P, Gendler SJ. Thompson EJ, et al. Among authors: gendler sj. Mol Cancer Res. 2006 Jul;4(7):489-97. doi: 10.1158/1541-7786.MCR-06-0038. Mol Cancer Res. 2006. PMID: 16849524

5

Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.

Basu GD, Pathangey LB, Tinder TL, Gendler SJ, Mukherjee P. Basu GD, et al. Among authors: gendler sj. Breast Cancer Res. 2005;7(4):R422-35. doi: 10.1186/bcr1019. Epub 2005 Apr 4. Breast Cancer Res. 2005. PMID: 15987447 Free PMC article.

6

Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis.

Al Masri A, Gendler SJ. Al Masri A, et al. Among authors: gendler sj. Oncogene. 2005 Sep 1;24(38):5799-808. doi: 10.1038/sj.onc.1208738. Oncogene. 2005. PMID: 15897873

7

MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation.

Schroeder JA, Masri AA, Adriance MC, Tessier JC, Kotlarczyk KL, Thompson MC, Gendler SJ. Schroeder JA, et al. Among authors: gendler sj. Oncogene. 2004 Jul 29;23(34):5739-47. doi: 10.1038/sj.onc.1207713. Oncogene. 2004. PMID: 15221004

8

MUC1 can interact with adenomatous polyposis coli in breast cancer.

Hattrup CL, Fernandez-Rodriguez J, Schroeder JA, Hansson GC, Gendler SJ. Hattrup CL, et al. Among authors: gendler sj. Biochem Biophys Res Commun. 2004 Apr 2;316(2):364-9. doi: 10.1016/j.bbrc.2004.02.072. Biochem Biophys Res Commun. 2004. PMID: 15020226

9

Downregulation of Muc1 in MMTV-c-Neu tumors.

Adriance MC, Gendler SJ. Adriance MC, et al. Among authors: gendler sj. Oncogene. 2004 Jan 22;23(3):697-705. doi: 10.1038/sj.onc.1207165. Oncogene. 2004. PMID: 14737104

10

MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion.

Schroeder JA, Adriance MC, Thompson MC, Camenisch TD, Gendler SJ. Schroeder JA, et al. Among authors: gendler sj. Oncogene. 2003 Mar 6;22(9):1324-32. doi: 10.1038/sj.onc.1206291. Oncogene. 2003. PMID: 12618757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results